Overall survival
EVENTS
OS events (any cause) occurred in 2/26 patients in Part A (median follow-up, 37.9 months; range, 4.6–47.0) and in 7/45 patients in Part B (median follow-up, 26.2 months; range, 9.5–33.1). Median OS estimates for Parts A and B separately and for the entire cohort were NR (range, NR–NR) (Fig. 